Litigation Details for Qorvo, Inc. v. Akoustis Technologies, Inc. (D. Del. 2021)
✉ Email this page to a colleague
Qorvo, Inc. v. Akoustis Technologies, Inc. (D. Del. 2021)
| Docket | ⤷ Start Trial | Date Filed | 2021-10-04 |
| Court | District Court, D. Delaware | Date Terminated | 2024-05-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Jon P. McCalla |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,385,008; 11,040,032; 11,098,015; 12,005,043; 12,005,051; 12,005,052; 9,056,052; 9,056,057; 9,061,005 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Qorvo, Inc. v. Akoustis Technologies, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , ⤷ Start Trial , and ⤷ Start Trial .
Biologic Drugs cited in Qorvo, Inc. v. Akoustis Technologies, Inc.
The biologic drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Qorvo, Inc. v. Akoustis Technologies, Inc. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2021-10-04 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
